Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy (Q37415993)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 February 2008
edit
Language Label Description Also known as
English
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy
scientific article published on 10 February 2008

    Statements

    Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy (English)
    Jane A Little
    Kristine Partovi Hauser
    Sabrina E Martyr
    Amy Harris
    Irina Maric
    Claudia R Morris
    Jung H Suh
    Oswaldo Castro
    Roberto Machado
    10 February 2008
    315-321

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit